Mode
Text Size
Log in / Sign up

Clinical Trial Search

Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.

Phase
Intervention
Population
Results posted

30 closest matches · ranked by relevance

N/A N=520 AMPLATZER™ LAA Occluder Post Approval Study (PAS)

Atrial Fibrillation · Thromboembolism · Stroke
Primary: Primary Effectiveness Endpoint 1: Composite Rate of Stroke (Including Ischemic or Hemorrhagic), Systemic Embolism and Cardiovascular or Unexplained Death — 14.28…
Abbott Medical Devices Results Mar 2024 38.7% serious AE View details

N/A N=1,878 AMPLATZER™ Amulet™ LAA Occluder Trial

Stroke
Primary: Primary Safety Endpoint: Composite Endpoint Rate of Procedure-related Complications, or All-cause Death or Major Bleeding (Defined as Type 3 or Greater Based on the…
Abbott Medical Devices Results Jan 2022 57.4% serious AE View details

Phase 2 N=13 Stroke Feasibility Study

Atrial Fibrillation · AFib
Primary: Number of Serious Adverse Events Within 30 Days Post-Index Procedure — 0 participants
AtriCure, Inc. Results Oct 2016 50.0% serious AE View details

N/A N=500 HEAL-LAA Clinical Trial

Atrial Fibrillation · Bleeding · Stroke
Primary: Primary Efficacy Endpoint: The Rate of Device Leak >5 mm at 45-day Post-Implant TEE for the Primary Analysis Subjects — 0 Participants
Boston Scientific Corporation Results Oct 2025 28.2% serious AE View details

N/A N=43 Watchman FLX Pro CT Pilot Study

Non-valvular Atrial Fibrillation (AF)
Primary: Number of Participants With Any Hypoattenuated Thickening (HAT) on the Surface of the Device — 3; 5; 5 Participants
Boston Scientific Corporation Results Dec 2025 53.5% serious AE View details